These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3625801)

  • 1. The myelodysplastic syndromes.
    Sims EG
    J Natl Med Assoc; 1987 Jul; 79(7):781-4. PubMed ID: 3625801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
    Aul C; Giagounidis A; Germing U; Ganser A
    Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, classification, and course of myelodysplastic syndromes.
    McKenna RW; Allison PM
    Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to treat myelodysplastic syndromes.
    Akhtari M
    Oncology (Williston Park); 2011 May; 25(6):480-6. PubMed ID: 21717901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplasia.
    Taylor KM; Rodwell RL; Taylor DL; Seeley GO
    Curr Opin Oncol; 1994 Jan; 6(1):32-40. PubMed ID: 8204690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes.
    Doll DC; List AF
    West J Med; 1989 Aug; 151(2):161-7. PubMed ID: 2672599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myeloproliferative syndromes].
    Ganser A
    Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic (preleukemia) syndromes: the bone marrow factory failure problem.
    Hoagland HC
    Mayo Clin Proc; 1995 Jul; 70(7):673-6; quiz 677. PubMed ID: 7791391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myelodysplastic syndromes.
    Nguyen PL
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience in pediatric myelodysplastic syndromes.
    Gadner H; Haas OA
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):655-72. PubMed ID: 1613011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications and treatment of the myelodysplastic syndromes.
    Tricot GJ
    Leuk Res; 1992; 16(1):117-21. PubMed ID: 1732664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
    Greenberg PL; Stone RM; Al-Kali A; Barta SK; Bejar R; Bennett JM; Carraway H; De Castro CM; Deeg HJ; DeZern AE; Fathi AT; Frankfurt O; Gaensler K; Garcia-Manero G; Griffiths EA; Head D; Horsfall R; Johnson RA; Juckett M; Klimek VM; Komrokji R; Kujawski LA; Maness LJ; O'Donnell MR; Pollyea DA; Shami PJ; Stein BL; Walker AR; Westervelt P; Zeidan A; Shead DA; Smith C
    J Natl Compr Canc Netw; 2017 Jan; 15(1):60-87. PubMed ID: 28040720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
    Paquette RL
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.